Ignite Creation Date:
2025-12-25 @ 4:41 AM
Ignite Modification Date:
2025-12-26 @ 3:43 AM
Study NCT ID:
NCT04282018
Status:
COMPLETED
Last Update Posted:
2024-12-06
First Post:
2020-02-05
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and Tislelizumab
Sponsor:
BeiGene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-05-25
Start Date Type:
ACTUAL
Primary Completion Date:
2024-08-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-08-28
Completion Date Type:
ACTUAL
First Submit Date:
2020-02-05
First Submit QC Date:
None
Study First Post Date:
2020-02-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-04
Last Update Post Date:
2024-12-06
Last Update Post Date Type:
ACTUAL